Aspen Pharmacare Market Cap 2017-2023 | APNHY
Aspen Pharmacare market cap history and chart from 2017 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Aspen Pharmacare market cap as of April 22, 2024 is $5.17B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $5.172B | $2.296B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.417B | 5.21 |
| Dr Reddy's Laboratories (RDY) | India | $11.872B | 18.77 |
| BridgeBio Pharma (BBIO) | United States | $4.350B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.175B | 2.48 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.955B | 13.38 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.609B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.425B | 0.00 |
| Generation Bio (GBIO) | United States | $0.186B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.074B | 0.00 |
| Personalis (PSNL) | United States | $0.065B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |